Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PSNL Personalis, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $16.40 +1.8% | $15.06 -2.2% |
| StockIQ Score | 51C- Moderate Risk: Medium | 35F Weak Risk: High |
| Technical | 63C+ | 13F |
| Fundamental | 27F | 35F |
| Growth | 48D+ | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 56C | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Personalis (PSNL) outperforms Ascentage Pharma (AAPG) in most categories. Its technical score of 79 is significantly higher than AAPG’s 18, showing stronger short-term trading strength. PSNL also has a moderate investor rating versus AAPG’s weak rating, though AAPG’s growth score (50) slightly edges out PSNL’s (48). Both share the same valuation score of 38.